ResMed | RMD - Ebitda

金融业

USD

USD 8.78B

现金及等价物

USD 1.66B

USD 551.67M

USD 4.06B

USD 1.35B

USD 847.72M

股息收益率

1.04

USD 505.67M

USD 547.48M

10.6K

EPS每股收益

USD 2.86

股本和储备

USD 6.49B

USD 890.98M

债务利息支出

USD 8.79M

USD 59K

USD 404.17M

USD 30.94B

USD 398.73M

USD 925.74M

USD 505.67M

普通股股本

USD 190.83M

21.21

USD 496.15M

USD 1.4B

销售和管理费用

USD 279.8M

USD 911.88M

贸易债权人

USD 273.3M

应收帐款人

USD 998.84M

	Ebitda	更改		日
Ansell	USD 185.8M		7M	2025-12
Artivion	USD 22.72M		1.84M	2025-12
AtriCure	USD 17.07M		2.79M	2026-03
Baxter International	USD -447M		873M	2025-12
Cochlear	AUD 306.4M		13.5M	2025-12
Cooper Companies	USD 323.4M		13.2M	2025-12
CSL	USD 3.13B		1.17B	2025-12
Dexcom	USD 364.5M		57.7M	2026-03
Edwards Lifesciences	USD 70.1M		394.2M	2025-12
Fisher Paykel Healthcare	NZD 364M		78.5M	2025-06
Globus Medical	USD 280.46M		27.86M	2025-12
Haemonetics	USD 94.78M		20.75M	2025-12
Idexx Laboratories	USD 400.87M		45.95M	2026-03
Insulet	USD 181.7M		12.3M	2026-03
Integra LifeSciences	USD 76.18M		28.03M	2026-03
Intuitive Surgical	USD 1.09B		165.5M	2025-12
Masimo	USD 85.5M		6.4M	2026-03
Medtronic	USD 2.93B		482M	2025-12
Philips	EUR 567M		233M	2026-03
Ramsay Health Care	AUD 1.12B		10.6M	2025-12
ResMed	USD 547.48M		27.46M	2025-12
Sigma Healthcare	AUD 19.96M		5.15M	2024-07
Sonic Healthcare	AUD 839.07M		51.09M	2024-12
Steris	USD 394.7M		5M	2025-12
Teleflex	USD 247.07M		575.88M	2025-12
Thermo Fisher Scientific	USD 2.7B		464M	2026-03